Polahist

Kraj: Nowa Zelandia

Język: angielski

Źródło: Medsafe (Medicines Safety Authority)

Składnik aktywny:

Dexchlorpheniramine maleate 2mg

Dostępny od:

BioInnova NZ Limited

Dawkowanie:

2 mg

Forma farmaceutyczna:

Tablet

Skład:

Active: Dexchlorpheniramine maleate 2mg Excipient: Lactose monohydrate Magnesium stearate Maize starch Pregelatinised maize starch Purified water

Typ recepty:

Restricted

Wskazania:

Symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and angioedema. Polahist/Polargen may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and medicine reactions, including serum sickness.

Podsumowanie produktu:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC ALU - 20 tablets - 36 months from date of manufacture stored at or below 25°C protect from light - Blister pack, PVC/PVDC ALU - 40 tablets - 36 months from date of manufacture stored at or below 25°C protect from light

Data autoryzacji:

2021-11-12